Jinhu Liu

Title: Jinhu Liu - Innovator in Pharmaceutical Chemistry

Introduction

Jinhu Liu is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of inhibitors that target specific cellular pathways. His innovative work has the potential to impact the treatment of various diseases.

Latest Patents

Jinhu Liu holds a patent for a preparation method for a CDK4/6 inhibitor. This method involves a compound of formula (I): 5-fluoro-4-(3-isopropyl-2-methyl-2H-indazol-5-yl)-N-(5-(piperazin-1-yl) pyrazol-2-yl)pyrimidine-2-amine. The preparation method utilizes cheap and readily available starting materials and reagents. It greatly simplifies the total reaction steps, shortens the reaction time, and improves the total yield and purity of the key intermediate and final product. This method is particularly suitable for industrial production.

Career Highlights

Jinhu Liu is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its practical applications in the pharmaceutical industry.

Collaborations

Jinhu Liu collaborates with notable colleagues, including Guofeng Liu and Yong Wang. Their combined expertise enhances the innovative capacity of their projects.

Conclusion

Jinhu Liu's contributions to pharmaceutical chemistry, particularly through his patent for a CDK4/6 inhibitor, demonstrate his commitment to advancing medical science. His work not only simplifies production processes but also holds promise for future therapeutic applications.